Skip to main content

Association between obesity and cervical intraepithelial neoplasia: results from a case control study in south western Uganda



Though obesity has been said to be associated with a number of malignancies including cervical cancer, its association with cervical intraepithelial neoplasia (CIN) is still a contentious issue. This study was designed to determining the prevalence and association between obesity and CIN.


This was an unmatched case control study, involving women with cervical intraepithelial neoplasia (cases) and those negative for intraepithelial lesions or malignancy (controls) at the cervical cancer clinic of Mbarara Regional Referral Hospital, in south-western Uganda, between April and November 2022. Cases and controls provided written informed consent and were recruited in a ratio of 1:1. Cases were identified by visual inspection with acetic acid (VIA) and subsequent confirmation with cytology and/or histology. Demographic information was collected using an enrolment form and height, weight and waist circumference were recorded. We calculated body mass index (BMI) and identified obese women as those with body mass index of ≥ 30 kg/m2 from both case and control groups. Central obesity was defined as waist: height ration of ≥ 0.5. Data was analysed using STATA version 17. Categorical variables were analysed using proportions, chi-square and logistic regression analysis to determine association between obesity and CIN. Our level of statistical significance was set at ≤ 0.05.


The prevalence of general and central obesity among cases was 25.5% (24/94) and 0% (0/94) respectively while the prevalence of general and central obesity among controls was 33.3% (37/111) and 0% (0/111) respectively. There was an increased prevalence of general obesity among women with low grade squamous intraepithelial lesions (LSIL). However, there was no statistically significant association between general obesity and CIN. Factors associated with general obesity included residing in Mbarara city (AOR 2.156, 95%CI 1.085–4.282, P-value 0.028), age group of 31–45 years (AOR 2.421, 95%CI 1.577–9.705, P-value 0.003) and ≥ 46 years (AOR 1.971, 95%CI 1.022–11.157, P-value 0.046).


We observed an increased prevalence of general obesity among women with LSIL. However, there was no association between obesity and CIN. Factors associated with general obesity included residing in Mbarara city, and being in the age groups of 31–40 and ≥ 46 years. This highlights the need to rethink management of CIN to control other non-communicable diseases that could arise due to general obesity.

Peer Review reports


World over, there were 770,828 incident cervical cancer cases in 2020 [1]. Cervical cancer is ranked the second most common cancer among women of reproductive age [2] and it accounts for more than 270 000 deaths annually, mostly in developing countries [3] and most especially in sub Saharan Africa [4, 5]. In the East African region, Cervical Cancer stands at 43/100,000 cancer cases [6], and over 4,000 new cases are recorded annually in Uganda [7]. A well-proven way to prevent cervical cancer is to screen and detect pre-cancers (CIN) before progressing to invasive cancer [3]. Other methods of cervical cancer prevention include vaccination for girls aged 9 to 14 years, health education for both boys and girls as well as treatment for all that need to be treated [1, 8, 9]. Vaccination as well as other factors has also been reported to be synergic to treatment [10] and it has an impact on the risk of developing persistence and recurrence of cervical dysplasia after treatment [11,12,13].

Cervical intraepithelial neoplasia (CIN) represents a precancerous stage that develops before cervical cancer [14, 15] and is mainly a result of infection with High Risk Human Papilloma Virus (HRHPV) [16]. Preventing CIN is still the best approach to eliminating the cervical cancer burden [17, 18].

It is important to understand other risk factors to CIN as this may lead to more targeted primary prevention strategies to address the current cervical cancer burden [14]. There are secondary factors that lead to HPV infection, its persistence and development of precancerous lesions [19].

An increased BMI has been associated with a number of disease conditions ranging from cardiovascular diseases (CVD) to cancers [20]. Obesity has been thought to increase one’s risk of developing cervical cancer [21]. It is hypothesised that increased BMI tends to impair one’s immune system, leading to persistent HPV infections, leading to cervical cancer [22,23,24]. The odds of having CIN are said to be higher for those women with increased BMI [14]. Obesity has previously been shown to be associated with increased cervical cancer risk [25,26,27,28,29]. However, in a broader picture, the association between BMI and CIN is not well understood [21, 30, 31]. This study was therefore aimed at determining if there is an association between obesity and cervical intraepithelial neoplasia.

Materials and methods

Study setting

The study was carried out among women attending the cervical cancer clinic of Mbarara Regional Referral Hospital. This clinic screens an average of 15 mothers per day and operates five days a week. It serves 13 districts of south western Uganda. The confirmatory tests for cervical intraepithelial lesions, PAP smears or histology are performed in the pathology department of the hospital/university.

Study design

This was an unmatched case control study. It included all women who sought cervical cancer screening services at the cervical cancer clinic of Mbarara Regional Referral Hospital. The cases were those women with a positive VIA and confirmed, with Pap smear cytology or histology, to have CIN while controls were those women with a negative VIA.

Sampling procedure

Cases and controls were selected prospectively. Cases were recruited using purposive sampling. Then we employed the incidence density sampling method to obtain controls i.e. we recruited a control each time a case was identified.

Sample size determination

The sample size was calculated using an online software, OpenEpi, Version 3, Open source calculator-SSCC. OpenEpi - Sample Size for Unmatched Case-Control Studies.

For this calculation, we considered a two-sided confidence level (1-alpha) of 95, a study power of 80%, a case to control ratio of 1, a proportion of cases with obesity as a component of metabolic syndrome of 40.99% [32] and a proportion of controls with obesity as a component of metabolic syndrome of 18.8% [33]. We also used the least extreme odds ratio of 3.0. This gave a minimum of 75 cases and 75 controls, considering module of Fleiss with continuity correction [34].

Data collection

Demographic data collection

Demographic data was collected using a pretested enrolment form which was administered by research assistants, the cervical cancer clinic midwives. Participants were explained to and taken through the consent process, filling the enrolment form and anthropometric measurements. The study PI performed random daily checks on the procedures to ensure conformity to the study requirements and validity as well as completeness of the data. Data collected included age, region of residence, age at first sexual debut, family planning usage, HIV status, CD4 count, HIV viral load, highest level of education, number of life-time sexual partners, marital status, history of blood pressure and history of diabetes.

Body Mass Index and anthropometric measurements

Measurements of height (in meters) and weight (in kilograms) were taken using calibrated stadiometer and weighing scale respectively. We also measured waist circumference (in meters). We calculated BMI as the weight in kilograms divided by the square of the height in meters. We then categorized BMI as non-obese (< 30 kg/m2) or obese (30 ≤ kg/m2) in accordance with standard cut off points by the World Health Organisation as used in previous studies [35, 36]. We defined central obesity using the World Health Organisation categorisation, as a waist to height ratio of ≥ 0.5 [35, 36].

Data management and analysis

Data was collected by the research assistants and the Principal Investigator. It was then entered into Microsoft Excel (Ms 2007), computer database, imported and analysed using STATA 17 software. Descriptive statistics were used to characterize the population using frequencies, means ± standard deviations (SDs) using the Ind. t test. Chi-square, Fisher’s exact test and logistic regression analysis were used to describe categorical variables and assess associations between obesity and categorical variables. Univariate analysis was done first and we purposively selected variables, with p-values < 0.1, for multivariate analysis. A P-value of ≤ 0.05 was considered to be statistically significant at multivariate analysis.

Eligibility criteria

We included all women of 21 years and above, who reported to the cervical cancer clinic of Mbarara Regional Referral Hospital during the time of the study, screened positive with VIA or HPV DNA, consented to participate in the study, and later confirmed to have a precancerous lesion (CIN) by either Pap smear or histology. Any woman that was moribund (too ill) to consent was excluded.


We recruited a total of 188 women (94 controls and 94 cases), following our inclusion criteria. There were 36/94 controls with general obesity and 24/94 cases with general obesity. This resulted in the prevalence of general obesity among controls and cases of 38% and 26% respectively. Results from demographics show non-significant differences between cases and controls. However, mean age of participants, contraceptive used and highest level of education varied significantly across cases and controls. Table 1.

Table 1 Comparison of obesity and other demographic characteristics between women with and those without Cervical Intraepithelial Neoplasia

Distribution of participant demographics with general obesity

The primary exposure of this study was obesity among participants with or without CIN. From all study participants, 60 participants had obesity while 128 were non obese. We observed a statistically significant difference in the distributions of age groups, HIV viral load, contraceptive use and age at sexual debut across obesity. Table 2.

Table 2 Distribution of participant demographics based on general obesity

Distribution of cytology results across general obesity

From the 60 study participants who had general obesity, 38.3% (23/60) were diagnosed with low grade squamous intraepithelial lesion. However, majority of low grade squamous intraepithelial lesions were diagnosed among non-obese women (45.3%). We observed a weakly significant distribution of cytology results across general obesity. Table 3.

Table 3 Distribution of cytology results based on general obesity

Factors associated with general obesity among study participants

We performed logistic regression analysis, first at bivariate and then multivariate. We found that residence in Mbarara city and being in the age groups of 31–45 and 45 ≤ were significantly associated with general obesity among the study participants. Table 4.

Table 4 Factors associated with general obesity among study participants

Association between obesity and grades of cervical intraepithelial neoplasia

Table 5 shows results from logistic regression analysis putting into account other demographic factors. General obesity did not show any statistically significant association with cervical intraepithelial neoplasia. University education and contraceptive usage were among the other factors that were significantly associated with cervical intraepithelial neoplasia.

Table 5 Logistic regression analysis showing association between general obesity and other factors and Cervical Intraepithelial Neoplasia


Obesity is one of the five components of metabolic syndrome that presents with unhealthy amounts and or distribution of fat in one’s body [37] and it is known to increase one’s chances of developing heart diseases and other non-communicable diseases including cervical cancer [38]. There is a reported increased mortality from cervical cancer among obese women [27]. Cervical cancer develops quite slowly, through precancerous stages called cervical intraepithelial neoplasia (CIN) [39]. Therefore, early detection of metabolic syndrome components in CIN is of great significance for prevention of heart and other related cardiovascular diseases.

To our knowledge, there is no other study that has reported prevalence and association between obesity and CIN in a Ugandan population. This study showed that the prevalence of general obesity was 26% among women with cervical intraepithelial neoplasia. General obesity, though not statistically significant, was more prevalent in participants with low grade squamous intraepithelial lesions (38.3%) compared with other grades but this observation was not statistically significant. Previous studies have equally found a similar finding [40]. The possible explanation for this high prevalence of obesity in CIN is that fact that there is an increased serum expression of sex hormones which themselves are thought to increase risk of cancer [41, 42].

This shows that much as many low grade squamous intraepithelial lesions regress on their own, there is an increased risk of coronary heart disease, diabetes, stroke and other cardiovascular diseases [38, 43,44,45] among patients with low grade squamous intraepithelial lesion due to obesity.

This study also showed that residing in Mbarara city and being in the age brackets of 31–45 and ≥ 46 were significantly associated with obesity among the study participants. It is important to note that the study site, Mbarara Regional Referral Hospital is located in Mbarara city, an urban city in South western Uganda with a relatively high socioeconomic status, and it contributed a big fraction of study participants. This could partly explain the high prevalence of obesity and its association with region of residence, since there is an association between obesity and a high socioeconomic status [46,47,48]. Similar findings about age and obesity were reported in a Nigerian population [49].

We did not find any association between obesity and cervical precancerous lesions. There have been a lot of inconsistencies in reported studies on association between obesity and CIN or cervical cancer [21, 25,26,27,28, 42, 50, 51]. However, our observation is consistent with some previous studies which have shown that obesity is not associated with cervical cancer or its precancerous lesions [21, 25,26,27,28,29, 42, 50]. For instance, a systematic review by Poorolajal et al. [21] only revealed a weak association between obesity and cervical cancer. A lower risk of CIN and higher risk of cervical cancer was reported among obese women [52] and this observation was attributed to a low detection rate of CIN among obese women [53, 54]. Similarly, a study among Thai women showed an increased prevalence of abnormal Pap smear results among obese women though not statistically significant [40].

To the contrary, an association between increased body mass index and a reduce risk of precancerous lesions was reported in a prospective cohort of Koreans [51]. Specifically, from a cross sectional study conducted in a Nigerian population, there was a reported association between obesity and epithelial cell abnormalities [49].

Strengths and limitations

We acknowledge that our study did not have a big sample size and this might have hindered observation of associations between variables. We also did not capture information on participant HPV vaccination status. Our current guidelines dictate vaccination of only young girls (9–14 years). In any case, we did not expect adults in our study to have been vaccinated considering the fact that HPV vaccination is a new intervention that has just been rolled out.


There was a high prevalence of obesity among women with CIN especially low grade squamous intraepithelial lesions. We did not observe any statistically significant association between obesity and CIN. Factors associated with obesity among our study participants included residence in Mbarara city and being in the age groups of 31–45 and ≥ 45 years. This emphasises the need to rethink management of CIN and cervical cancer to control other non-communicable diseases that could arise due to obesity. We recommend prospective cohort studies to further understand obesity and CIN as well as cervical cancer.

Data Availability

All data from which this article was generated is available from the corresponding author upon meaningful request.



Cervical Intraepithelial neoplasia


Visual Inspection with acetic acid


Loop Electrosurgical Excision Procedure




Body Mass Index


Low Grade Squamous Intraepithelial Lesion


Statistical Software for Data Science


Adjusted Odds Ratio


Odds Ratio


Confidence Interval


Standard Deviation


Human Papilloma Virus


Cardiovascular Disease


Human Immunodeficiency Virus


  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209–49.

    Article  Google Scholar 

  2. Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J et al. ICO/IARC information centre on HPV and cancer (HPV information centre).Human papillomavirus and related diseases in the world Summary Report. 2019;17(6).

  3. Organization WH. Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2019 global survey. 2020.

  4. Anorlu RI. Cervical cancer: the sub-saharan african perspective. Reprod Health Matters. 2008;16(32):41–9.

    Article  PubMed  Google Scholar 

  5. Denny L, Quinn M, Sankaranarayanan R. Screening for cervical cancer in developing countries. Vaccine. 2006;24:71–S7.

    Article  Google Scholar 

  6. Sankaranarayanan R. Screening for cancer in low-and middle-income countries. Annals of global health. 2014;80(5):412–7.

    Article  CAS  PubMed  Google Scholar 

  7. Botha H, Cooreman B, Dreyer G, Lindeque G, Mouton A, Guidozzi F, et al. Cervical cancer and human papillomavirus: south african guidelines for screening and testing: clinical guidelines. South Afr J Gynaecol Oncol. 2010;2(1):23–6.

    Article  Google Scholar 

  8. Stelzle D, Tanaka LF, Lee KK, Khalil AI, Baussano I, Shah AS, et al. Estimates of the global burden of cervical cancer associated with HIV. 2021;9(2):e161–e9.

    CAS  Google Scholar 

  9. Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, et al. HPV vaccination and the risk of invasive cervical cancer. 2020;383(14):1340–8.

    CAS  Google Scholar 

  10. Di Tucci C, Schiavi MC, Faiano P, D’Oria O, Prata G, Sciuga V et al. Therapeutic vaccines and immune checkpoints inhibition options for gynecological cancers. 2018;128:30–42.

  11. Bogani G, Raspagliesi F, Sopracordevole F, Ciavattini A, Ghelardi A, Simoncini T et al. Assessing the long-term role of vaccination against hpv after loop electrosurgical excision procedure (Leep): A propensity-score matched comparison. 2020;8(4):717.

  12. Bogani G, Sopracordevole F, Di Donato V, Ciavattini A, Ghelardi A, Lopez S et al. High-risk HPV-positive and-negative high-grade cervical dysplasia: Analysis of 5-year outcomes. 2021;161(1):173–8.

  13. Bogani G, Lalli L, Sopracordevole F, Ciavattini A, Ghelardi A, Simoncini T et al. Development of a nomogram predicting the risk of persistence/recurrence of cervical dysplasia. 2022;10(4):579.

  14. Taye BT, Mihret MS, Muche HA. Risk factors of precancerous cervical lesions: the role of women’s socio-demographic, sexual behavior and body mass index in Amhara region referral hospitals; case-control study. PLoS ONE. 2021;16(3):e0249218.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Teame H, Addissie A, Ayele W, Hirpa S, Gebremariam A, Gebreheat G, et al. Factors associated with cervical precancerous lesions among women screened for cervical cancer in Addis Ababa, Ethiopia: a case control study. PLoS ONE. 2018;13(1):e0191506.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Kebede HM, Hailay SB, Teklehaymanot HA. Prevalence of precancerous cervical lesion and associated factors among women in North Ethiopia. J Public Health Epidemiol. 2017;9(3):46–50.

    Article  Google Scholar 

  17. Ntekim A. Cervical cancer in sub Sahara Africa. Top Cerv cancer advocacy Prev. 2012;4:54–9.

    Google Scholar 

  18. Denny L. Cervical cancer prevention: new opportunities for primary and secondary prevention in the 21st century. Int J Gynecol Obstet. 2012;119:80–S4.

    Article  Google Scholar 

  19. Asseffa NA. Cervical cancer: Ethiopia’s outlook. J Gynecol Womens Health. 2017;5(2):555660.

    Article  Google Scholar 

  20. Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief, no 360. National Center for Health Statistics. 2020(360).

  21. Poorolajal J, Jenabi E. The association between BMI and cervical cancer risk: a meta-analysis. Eur J Cancer Prev. 2016;25(3):232–8.

    Article  CAS  PubMed  Google Scholar 

  22. Benedetto C, Salvagno F, Canuto EM, Gennarelli G. Obesity and female malignancies. Best Pract Res Clin Obstet Gynecol. 2015;29(4):528–40.

    Article  Google Scholar 

  23. Eifel PJ, Jhingran A, Bodurka DC, Levenback C, Thames H. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol. 2002;20(17):3651–7.

    Article  PubMed  Google Scholar 

  24. Gu W, Chen C, Zhao K-N. Obesity-associated endometrial and cervical cancers. Front Bioscience-Elite. 2013;5(1):109–18.

    Article  Google Scholar 

  25. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the million women study: cohort study. BMJ. 2007;335(7630):1134.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Frumovitz M, Jhingran A, Soliman PT, Klopp AH, Schmeler K, Eifel PJ. Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer. Obstet Gynecol. 2014;124(6):1098.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med. 2003;348(17):1625–38.

    Article  PubMed  Google Scholar 

  28. Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5· 24 million UK adults. The Lancet. 2014;384(9945):755–65.

    Article  Google Scholar 

  29. Song Y-M, Sung J, Ha M. Obesity and risk of cancer in postmenopausal korean women. J Clin Oncol. 2008;26(20):3395–402.

    Article  PubMed  Google Scholar 

  30. Feng Y-H. The association between obesity and gynecological cancer. Gynecol Minim Invasive Therapy. 2015;4(4):102–5.

    Article  Google Scholar 

  31. Wee CC, Huang A, Huskey KW, McCarthy EP. Obesity and the likelihood of sexual behavioral risk factors for HPV and cervical cancer. Obesity. 2008;16(11):2552–5.

    Article  PubMed  Google Scholar 

  32. Ahn HK, Shin JW, Ahn HY, Park C-Y, Lee NW, Lee JK, et al. Metabolic components and recurrence in early-stage cervical cancer. Tumor Biology. 2015;36(3):2201–7.

    Article  CAS  PubMed  Google Scholar 

  33. Kim M, Kim I-H, Lim MK, Kim Y, Park B. Increased prevalence of metabolic syndrome in adult cancer survivors: asian first report in community setting. Cancer Epidemiol. 2019;58:130–6.

    Article  PubMed  Google Scholar 

  34. Fleiss JL, Levin B, Paik MC. Statistical methods for rates and proportions. john wiley & sons; 2013.

  35. Onis Md, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann JJBotWhO. Development of a WHO growth reference for school-aged children and adolescents. 2007;85(9):660–7.

  36. Weir CB, Jan A. BMI classification percentile and cut off points. 2019.

  37. Garvey WT, Mechanick JI. Proposal for a scientifically correct and medically actionable disease classification system (ICD) for obesity. Obesity. 2020;28(3):484–92.

    Article  PubMed  Google Scholar 

  38. Cohen SS, Park Y, Signorello LB, Patel AV, Boggs DA, Kolonel LN, et al. A pooled analysis of body mass index and mortality among African Americans. PLoS ONE. 2014;9(11):e111980.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Balasubramaniam SD, Balakrishnan V, Oon CE, Kaur G. Key molecular events in cervical cancer development. Medicina. 2019;55(7):384.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Prompakay R, Promthet S, Kamsa-Ard S, Suwanrungruang K, Wiangnon S, Bradshaw P. Relationship between the body mass index and abnormal pap smears. Asian Pac J Cancer Prev. 2013;14(9):5503–6.

    Article  PubMed  Google Scholar 

  41. Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr. 1987;45(1):277–82.

    Article  CAS  PubMed  Google Scholar 

  42. Lacey JV Jr, Swanson CA, Brinton LA, Altekruse SF, Barnes WA, Gravitt PE, et al. Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2003;98(4):814–21.

    Article  Google Scholar 

  43. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363(23):2211–9.

    Article  CAS  PubMed  Google Scholar 

  44. Kitahara CM, Flint AJ, Berrington de Gonzalez A, Bernstein L, Brotzman M, MacInnis RJ, et al. Association between class III obesity (BMI of 40–59 kg/m2) and mortality: a pooled analysis of 20 prospective studies. PLoS Med. 2014;11(7):e1001673.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355(8):763–78.

    Article  CAS  PubMed  Google Scholar 

  46. Zhang Q, Wang Y. Trends in the association between obesity and socioeconomic status in US adults: 1971 to 2000. Obes Res. 2004;12(10):1622–32.

    Article  PubMed  Google Scholar 

  47. Hruby A, Hu FB. The epidemiology of obesity: a big picture. PharmacoEconomics. 2015;33(7):673–89.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Anekwe CV, Jarrell AR, Townsend MJ, Gaudier GI, Hiserodt JM, Stanford FC. Socioeconomics of obesity. Curr Obes Rep. 2020;9(3):272–9.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Okoro SO, Ajah LO, Nkwo PO, Aniebue UU, Ozumba BC, Chigbu CO. Association between obesity and abnormal papanicolau (pap) smear cytology results in a resource-poor nigerian setting. BMC Womens Health. 2020;20(1):1–8.

    Article  Google Scholar 

  50. Kizer NT, Thaker PH, Gao F, Zighelboim I, Powell MA, Rader JS, et al. The effects of body mass index on complications and survival outcomes in patients with cervical carcinoma undergoing curative chemoradiation therapy. Cancer. 2011;117(5):948–56.

    Article  PubMed  Google Scholar 

  51. Lee JK, So KA, Piyathilake CJ, Kim MK. Mild obesity, physical activity, calorie intake, and the risks of cervical intraepithelial neoplasia and cervical cancer. PLoS ONE. 2013;8(6):e66555.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Clarke MA, Fetterman B, Cheung LC, Wentzensen N, Gage JC, Katki HA, et al. Epidemiologic evidence that excess body weight increases risk of cervical cancer by decreased detection of precancer. J Clin Oncol. 2018;36(12):1184.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Maruthur NM, Bolen SD, Brancati FL, Clark JM. The association of obesity and cervical cancer screening: a systematic review and meta-analysis. Obesity. 2009;17(2):375–81.

    Article  PubMed  Google Scholar 

  54. Meisinger C, Heier M, Loewel H. The relationship between body weight and health care among german women. Obes Res. 2004;12(9):1473–80.

    Article  PubMed  Google Scholar 

Download references


We acknowledge the staff of Mbarara Regional Referral Hospital, especially the cervical cancer screening and prevention clinic.


This research project was entirely funded by The Mbarara University Research Capacity Initiative (MURCI) Program funded by the National Institutes of Health (NIH) under grant number D43TW011632-01.

Author information

Authors and Affiliations



The corresponding author, FS, conceived the idea and developed the first draft of the manuscript. Co-authors TCR, DT and JN (Joseph Ngonzi) supervised the whole project from data collection to analysis. They reviewed and provided overall guidance in the entire write up and approved the final version prior to submission. JNN (Josephine Nambi Najjuma) and RK participated in data analysis, reviewed and approved the final version of the manuscript. All authors are accountable to all aspects of this manuscript.

Corresponding author

Correspondence to Frank Ssedyabane.

Ethics declarations

Ethics approval and consent to participate

Informed consent was sought from every participant as well as legal representatives for illiterate participants before taking part in the study. We used study numbers not names on all data collection tools. We delinked all participant identifiable information during data analysis. All participant interaction with the research team took place in a private and comfortable room, free from other disturbances and only accessible to one participant at a time. Ethical review and approval was sought from Mbarara University of Science and Technology Research Ethics Committee (MUST-2022-396) and Uganda National Council for Science and Technology (HS2395ES). Administrative clearance was also sought from the Hospital Director, Mbarara Regional Referral Hospital, before commencement of the study. All women diagnosed with cervical intraepithelial lesions (cases) received the standard package of care at the cervical cancer clinic. Participants were provided with their VIA, Pap smear, Histology and BMI results by the nurse at the clinic. All methods involved in this study were carried out in accordance with relevant guidelines and regulations.

Consent for publication

Not applicable.

Competing interests

We, the authors declare that we do not have any competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ssedyabane, F., Ngonzi, J., Kajabwangu, R. et al. Association between obesity and cervical intraepithelial neoplasia: results from a case control study in south western Uganda. BMC Women's Health 23, 159 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: